Clinical Trials
Clinical Trials
For more information, please visit: clinicaltrials.gov
- Characterization of Immune Cell Infiltrations
Principal Investigator: Sunil Singhal, MD
- A Phase 2, Open-label Study to Evaluate the Safety and Efficacy of VGT-309, a Tumor-Targeted, Activatable Fluorescent Imaging Agent, to Identify Cancer in Subjects Undergoing Lung Cancer Surgery NCT05400226
Principal Investigator: Sunil Singhal, MD
Sponsor: Vergent Bioscience, Inc.
- A Phase 2, single-dose, open-label study to evaluate diagnostic performance and safety of Pegsitacianine, an intraoperative fluorescence imaging agent for the detection of Lung Malignancies, in patients undergoing Routine surgery NCT05048082
Principal Investigator: Sunil Singhal, MD
Sponsor: OncoNano Medicine, Inc.
- Intraoperative Imaging of Pulmonary Nodules by OTL
NCT02602119
Principle Investigator: Sunil Singhal, MD
Sponsor: University of Pennsylvania
- Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry
Optional Sub-Study I: ICG
Optional Sub-Study II: OTL38
NCT02852252
Principle Investigator: Sunil Singhal, MD
Sponsor: University of Pennsylvania
- Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer
NCT03131037
Principle Investigator: Sunil Singhal, MD
Sponsor: Advantagene, Inc.
- A Pilot, Single dose, Open-Label Study of OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer - Comparing Camera Imaging Systems.
Principle Investigator: Sunil Singhal, MD
Sponsor: On Target Laboratories, Inc.
- Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer.
NCT03659448
Principle Investigator: Sunil Singhal, MD
Sponsor: SurgiMab
- NIR Imaging of Lung Cancer Specimens
Principle Investigator: Sunil Singhal, MD
Sponsor: Vergent Bioscience
- Intraoperative Imaging of Pulmonary Nodules by SGM-101
NCT04315467
Principle Investigator: Sunil Singhal, MD
Sponsor: Sunil Singhal
- ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting / A Phase 3, Randomized, Single dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
NCT04241315
Principle Investigator: Sunil Singhal, MD
Sponsor: On Target Laboratories, Inc.